{"id":"https://openalex.org/W4367302599","doi":"https://doi.org/10.1212/wnl.0000000000202342","title":"Effects of Ozanimod on Cognitive Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials (P6-3.001)","display_name":"Effects of Ozanimod on Cognitive Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials (P6-3.001)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367302599","doi":"https://doi.org/10.1212/wnl.0000000000202342"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000202342","doi":"https://doi.org/10.1212/wnl.0000000000202342","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202342","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061524175","display_name":"John DeLuca","orcid":"https://orcid.org/0000-0003-3745-4156","observed_orcids":["https://orcid.org/0000-0003-3745-4156"]},"institutions":[{"id":"https://openalex.org/I250153783","display_name":"Kessler Foundation","ror":"https://ror.org/05hacyq28","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I250153783"]},{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John DeLuca","raw_affiliation_strings":["Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey","institution_ids":["https://openalex.org/I250153783","https://openalex.org/I4402554120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053403281","display_name":"Jeffrey A. Cohen","orcid":"https://orcid.org/0000-0001-9245-9772","observed_orcids":["https://orcid.org/0000-0001-9245-9772"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Cohen","raw_affiliation_strings":["Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020903163","display_name":"Bruce Cree","orcid":"https://orcid.org/0000-0001-7689-2533","observed_orcids":["https://orcid.org/0000-0001-7689-2533"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce A. C. Cree","raw_affiliation_strings":["Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045005523","display_name":"Chun-Yen Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chun-Yen Cheng","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035893022","display_name":"James K. Sheffield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James K. Sheffield","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090633862","display_name":"Jon V. Riolo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon V. Riolo","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Diego Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diego Silva","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Giancarlo Comi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154387261","display_name":"Vita-Salute San Raffaele University","ror":"https://ror.org/01gmqr298","country_code":"IT","type":"education","lineage":["https://openalex.org/I154387261"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giancarlo Comi","raw_affiliation_strings":["Vita-Salute San Raffaele University, and Casa di Cura del Policlinico, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vita-Salute San Raffaele University, and Casa di Cura del Policlinico, Milan, Italy","institution_ids":["https://openalex.org/I154387261"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054874316","display_name":"Ludwig Kappos","orcid":"https://orcid.org/0000-0003-4175-5509","observed_orcids":["https://orcid.org/0000-0003-4175-5509"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ludwig Kappos","raw_affiliation_strings":["Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5971,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.6434213,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ozanimod","display_name":"ozanimod","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/processing-speed","display_name":"processing speed","score":0.996999979019165},{"id":"https://openalex.org/keywords/symbol-digit-modalities-test","display_name":"Symbol Digit Modalities Test","score":0.9490000009536743},{"id":"https://openalex.org/keywords/interferon-beta-1a","display_name":"interferon beta-1a","score":0.9710000157356262},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.3050000071525574},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.37299999594688416},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.4449999928474426},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C2778029271","wikidata":"https://www.wikidata.org/wiki/Q5421931","display_name":"Extension (predicate logic)","level":2,"score":0.7088063955307007},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.428469717502594},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3226873278617859},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.31376177072525024},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.107280433177948},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000202342","doi":"https://doi.org/10.1212/wnl.0000000000202342","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202342","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3138150270","https://openalex.org/W4394600643","https://openalex.org/W3112161524","https://openalex.org/W4410288309","https://openalex.org/W4412592901","https://openalex.org/W4399175468","https://openalex.org/W4229989402","https://openalex.org/W3108127203","https://openalex.org/W4367303074","https://openalex.org/W4394601038"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"evaluate":[2],"the":[3,25,42,56,83,107,152,266,309,327,345,363,393,411,429,447,465,484,503,531,552,573,595,616,637,659,680,701,719,738,756,774,793,811,829,847,963,981,999,1019,1037,1056,1077,1096,1121],"long-term":[4],"effects":[5],"of":[6,100,109,176,204,213,259,270,281,311,329,347,365,377,395,413,431,449,467,486,505,523,533,544,554,565,575,587,597,608,618,629,639,651,661,672,682,693,703,721,740,758,776,795,813,831,849,867,900,915,928,943,965,983,1001,1021,1039,1058,1079,1098,1123,1141,1152,1163,1174,1185,1196,1208,1219,1230,1241,1252,1263,1286,1297,1309,1322,1334,1347,1359,1373,1386],"ozanimod":[7,31,71,101,138,146,180,209,271,277],"on":[8,369,853,1043,1062,1083],"cognitive":[9],"processing":[10],"speed":[11],"(CPS)":[12],"in":[13,48,133,201,308,326,344,362,392,410,428,446,464,483,502,530,551,572,594,615,636,658,679,700,718,737,755,773,792,810,828,846,962,980,998,1018,1036,1055,1076,1095,1120],"relapsing":[14],"multiple":[15],"sclerosis":[16],"(RMS)":[17],"patients":[18],"over":[19,52],"60":[20],"months":[21],"(M).":[22],"Background:":[23],"In":[24,55],"phase":[26],"3":[27,295],"SUNBEAM":[28,59,80,122,143,169],"trial":[29,98],"(NCT02294058),":[30],"treatment":[32],"improved":[33],"CPS":[34,262,284],"vs":[35],"interferon":[36],"\u03b2-1a":[37],"(IFN),":[38],"as":[39,315,333,351,399,417,435,453,471,490,509,537,558,579,601,622,643,665,686,707,725,744,762,780,799,817,835,897,912,925,940,969,987,1005,1025,1102,1127],"measured":[40],"with":[41,50,64,111,261,275,283],"Symbol":[43],"Digit":[44],"Modalities":[45],"Test":[46],"(SDMT),":[47],"participants":[49,110,144,177,260,282],"RMS":[51,65],"12M.":[53],"Design/Methods:":[54],"double-blind,":[57],"double-dummy,":[58],"trial,":[60],"adults":[61],"(18\u201355":[62],"years)":[63],"were":[66,91,154,161],"randomized":[67,136,178],"to":[68,121,137,179,217,299,886,1409],"once-daily":[69],"oral":[70],"0.92":[72],"or":[73,75,118,140,514,857,950,1107,1132,1406],"0.46mg,":[74],"weekly":[76],"intramuscular":[77],"IFN":[78,289],"30\u03bcg.":[79],"continued":[81],"until":[82],"last":[84],"participant":[85],"was":[86,199],"treated":[87],"for":[88,93,313,318,331,336,349,354,367,373,397,402,415,420,433,438,451,456,469,474,488,493,507,519,535,540,556,561,577,582,599,604,620,625,641,646,663,668,684,689,705,710,723,728,742,747,760,765,778,783,797,802,815,820,833,838,851,862,895,910,923,938,967,972,985,990,1003,1008,1023,1028,1041,1047,1060,1066,1081,1087,1100,1112,1125,1137],"12M;":[89],"completers":[90],"eligible":[92],"an":[94,510,898,913,926,941,951,1103,1128],"open-label":[95],"extension":[96],"(OLE)":[97],"(DAYBREAK\u2013NCT02576717)":[99],"0.92mg.":[102],"This":[103],"exploratory":[104],"analysis":[105],"reports":[106],"percentage":[108,258,280],"clinically":[112],"meaningful":[113],"(\u22654":[114],"point)":[115],"SDMT":[116,159,186],"improvement":[117,198,263,285],"worsening":[119],"relative":[120],"baseline":[123,158],"at":[124,127],"12M,":[125],"and":[126,131,164,173,182,188,191,210,221,231,237,246,252],"OLE":[128,153,196,227,242],"M12,":[129,170,197],"M36,":[130,228],"M60":[132],"those":[134,205,214],"initially":[135],"0.92mg":[139,181],"IFN.":[141],"Results:":[142],"(n=397,":[145],"0.92mg;":[147],"n=395,":[148],"IFN)":[149],"who":[150,206,286],"entered":[151],"analyzed.":[155],"Mean":[156],"(SE)":[157],"scores":[160],"48.0":[162],"(0.69)":[163],"47.4":[165],"(0.68),":[166],"respectively.":[167,225],"At":[168,195,226,241],"34.5%":[171],"(137/397)":[172],"27.8%":[174],"(110/395)":[175],"IFN,":[183],"respectively,":[184],"had":[185],"improvement,":[187],"23.2%":[189],"(92/397)":[190],"28.1%":[192,238],"(111/395)":[193],"worsened.":[194,240,255],"seen":[200],"43.2%":[202],"(171/396)":[203],"received":[207,288,305,323,341,359,381,389,407,425,443,461,480,499,527,548,569,591,612,633,655,676,697,715,734,752,770,789,807,825,843,871,879,892,907,920,935,948,959,977,995,1015,1033,1052,1073,1092,1117,1145,1156,1167,1178,1189,1200,1212,1223,1234,1245,1256,1267,1290,1301,1313,1326,1338,1351,1363,1377,1390,1399],"continuous":[208,276],"34.8%":[211],"(135/388)":[212],"originally":[215],"assigned":[216],"IFN;":[218],"19.9%":[219],"(79/396)":[220],"24.7%":[222],"(96/388)":[223],"worsened,":[224],"40.0%":[229],"(144/360)":[230],"40.1%":[232],"(137/342)":[233],"improved;":[234,249],"23.1%":[235],"(83/360)":[236],"(96/342)":[239],"M60,":[243],"41.5%":[244],"(134/323)":[245],"36.8%":[247],"(112/304)":[248],"26.0%":[250],"(84/323)":[251],"27.3%":[253],"(83/304)":[254],"Conclusions:":[256],"The":[257,279,375,521,542,563,585,606,627,649,670,691,865,1139,1150,1161,1172,1183,1194,1206,1217,1228,1239,1250,1261,1284,1295,1307,1320,1332,1345,1357,1371,1384],"increased":[264],"during":[265],"first":[267],"2\u20133":[268],"years":[269,296],"treatment,":[272],"then":[273],"maintained":[274],"treatment.":[278],"previously":[287],"reached":[290],"a":[291,316,334,352,370,400,418,436,454,472,491,538,559,580,602,623,644,666,687,708,726,745,763,781,800,818,836,854,883,970,988,1006,1026,1044,1063,1084,1404],"similar":[292],"proportion":[293],"within":[294],"after":[297],"switching":[298],"ozanimod.":[300],"Disclosure:":[301],"Dr.":[302,320,338,356,378,386,404,422,440,458,477,496,524,545,566,588,609,630,652,673,694,712,731,749,767,786,804,822,840,868,876,904,917,956,974,992,1012,1030,1049,1070,1089,1114,1142,1153,1164,1175,1186,1197,1209,1220,1231,1242,1253,1264,1287,1298,1310,1323,1335,1348,1360,1374,1387,1396],"DeLuca":[303,321,339,357,379],"has":[304,322,340,358,380,388,406,424,442,460,479,498,526,547,568,590,611,632,654,675,696,714,733,751,769,788,806,824,842,870,878,891,906,919,934,947,958,976,994,1014,1032,1051,1072,1091,1116,1144,1155,1166,1177,1188,1199,1211,1222,1233,1244,1255,1266,1289,1300,1312,1325,1337,1350,1362,1376,1389,1398],"personal":[306,324,342,360,390,408,426,444,462,481,500,528,549,570,592,613,634,656,677,698,716,735,753,771,790,808,826,844,893,908,921,936,960,978,996,1016,1034,1053,1074,1093,1118],"compensation":[307,325,343,361,391,409,427,445,463,482,501,529,550,571,593,614,635,657,678,699,717,736,754,772,791,809,827,845,894,909,922,937,961,979,997,1017,1035,1054,1075,1094,1119],"range":[310,328,346,364,394,412,430,448,466,485,504,532,553,574,596,617,638,660,681,702,720,739,757,775,794,812,830,848,964,982,1000,1020,1038,1057,1078,1097,1122],"$500-$4,999":[312,330,414,432,450,468,487,506,619,662,683,704,722,759,777,796,814,832,850,966,984,1002,1022,1040,1059,1080,1099,1124],"serving":[314,332,350,368,398,416,434,452,470,489,508,536,557,578,600,621,642,664,685,706,724,743,761,779,798,816,834,852,896,911,924,939,968,986,1004,1024,1042,1061,1082,1101,1126],"Consultant":[317,335,353,401,419,437,455,473,492,539,560,581,603,624,645,667,688,709,727,746,764,782,801,819,837,971,989,1007,1027],"Novartis.":[319,605,1029,1088,1227],"Biogen.":[337,374,385,439,562,1160],"$10,000-$49,999":[348,366,396,576,598],"Celgene.":[355],"Speakers":[371,1045,1064,1085],"Bureau":[372,1046,1065,1086],"institution":[376,522,543,564,586,607,628,650,671,692,866,1140,1151,1162,1173,1184,1195,1207,1218,1229,1240,1251,1262,1285,1296,1308,1321,1333,1346,1358,1372,1385],"research":[382,872,1146,1157,1168,1179,1190,1201,1213,1224,1235,1246,1257,1268,1291,1302,1314,1327,1339,1352,1364,1378,1391],"support":[383,873,1147,1158,1169,1180,1191,1202,1214,1225,1236,1247,1258,1269,1292,1303,1315,1328,1340,1353,1365,1379,1392],"from":[384,874,882,954,1148,1159,1170,1181,1192,1203,1215,1226,1237,1248,1259,1270,1293,1304,1316,1329,1341,1354,1366,1380,1393,1403],"Cohen":[387,405,423,441,459,478,497],"Convelo.":[403],"Mylan.":[421],"PSI.":[457],"EMD":[475,583,1330],"Serono.":[476,584,1205,1331],"Gossamer":[494,729],"Bio.":[495,730],"Editor,":[511,513,1104,1106,1129,1131],"Associate":[512,1105,1130],"Editorial":[515,1108,1133],"Advisory":[516,856,1109,1134],"Board":[517,1110,1135],"Member":[518,1111,1136],"Sage.":[520],"Cree":[525,546,567,589,610,631,653,674,695,713,732,750,768,787,805,823,841,869,877],"$5,000-$9,999":[534,555,640,741],"Atara.":[541],"Sanofi.":[626,973,1249],"TG":[647],"Therapeutics.":[648],"Autobahn.":[669],"Avotres.":[690],"Alexion.":[711],"Horizon.":[748],"Neuron23.":[766],"Boston":[784],"Pharma.":[785],"Hexal/Sandoz.":[803],"Siemens.":[821],"Therini.":[839],"Scientific":[855],"Data":[858],"Safety":[859],"Monitoring":[860],"board":[861],"Immunic":[863],"AG.":[864,1319,1356],"Genentech.":[875,1171],"publishing":[880],"royalties":[881],"publication":[884],"relating":[885,1408],"health":[887,1410],"care.":[888,1411],"Mr.":[889],"Cheng":[890],"employee":[899,914,927,942],"Bristol":[901,929,1009,1067,1381],"Myers":[902,930,1010,1068,1382],"Squibb.":[903,1011,1069,1383],"Sheffield":[905],"BMS.":[916,944,955],"Riolo":[918],"Squib.":[931],"Diego":[932,945],"Silva":[933,946],"stock":[949],"ownership":[952],"interest":[953],"Comi":[957,975,993,1013,1031,1050,1071,1090,1115],"Janssen.":[991,1048,1113,1193],"Rewind.":[1138],"Kappos":[1143,1154,1165,1176,1187,1198,1210,1221,1232,1243,1254,1265,1288,1299,1311,1324,1336,1349,1361,1375,1388,1397],"Bayer.":[1149],"Genzyme.":[1182],"Merck":[1204],"Minoryx.":[1216],"Roche.":[1238],"Santhera.":[1260],"Swiss":[1271,1274],"MS":[1272],"Society,":[1273],"National":[1275],"Research":[1276,1281],"Foundation,":[1277,1282],"European":[1278],"Union,":[1279],"Roche":[1280],"Innosuisse.":[1283],"Shionogi.":[1294],"Japan":[1305],"Tobacco.":[1306],"Auriga":[1317],"Vision":[1318],"Glaxo":[1342],"Smith":[1343],"Kline.":[1344],"Wellmera":[1355],"Eli":[1367],"Lilly":[1368],"(Suisse)":[1369],"SA.":[1370],"Celltrion":[1394],"Inc.":[1395],"intellectual":[1400],"property":[1401],"interests":[1402],"discovery":[1405],"technology":[1407]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-04-29T00:00:00"}